Skip to content
AI News HubLIVE
More
Summary only

Anthropic wants to develop its own drugs

Anthropic announced Claude Science, an AI workbench for scientists, and plans to develop its own drugs for neglected diseases. Experts highlight challenges in AI-driven drug discovery, including experimental validation and data scarcity, with no AI-designed drug yet approved.

SourceThe Verge AIAuthor: Robert Hart
Anthropic wants to develop its own drugs
Report an error

The correction channel is not available yet. You can copy the article reference below for later.

Correction instructions

Summary only

Under the source content permission, this page provides an editorial summary, key points, and a link to the original article.

Key points and analysis

Article intelligence

InvestorsAdvanced

Key points

  • Anthropic launches Claude Science, an AI workbench for scientists integrating tools and datasets.
  • Company announces plans to develop its own drugs, focusing on neglected diseases.
  • Experts note AI can accelerate research but drugs still need lengthy real-world testing; no AI-designed drug has been approved.
  • Anthropic is hiring biologists and building wet labs.

Highlights and analysis are generated automatically and may contain errors. Check the original source.

More recent stories on this topic · Research